Angiogenesis and new bone formation in novel unidirectional porous beta-tricalcium phosphate: a histological study

J Artif Organs. 2019 Dec;22(4):294-299. doi: 10.1007/s10047-019-01120-8. Epub 2019 Jul 19.

Abstract

Affinos® (Kuraray Co., Ltd., Tokyo, Japan) is a beta-tricalcium phosphate (TCP) artificial bone comprising a novel unidirectional porous structure with 57% porosity. This study examined angiogenesis and bone formation over time with unidirectional porous beta-TCP (UDPTCP). Ten Japanese White rabbits were used in this study. A 5 × 8-mm rectangular area of periosteum was resected, followed by preparation of a cortical bone defect using a high-speed bur. UDPTCP was embedded in the defect in the direction of the pores, parallel to the axis of the tibia. Tissue samples were harvested at 2 weeks (n = 3) and 6 weeks (n = 7) after implantation. Just before euthanasia, the vasculature of the lower limb was perfused with saline from the femoral artery and filled with MICROFIL® (Flow Tech, Inc., Carver, MA) to create a vascular cast. The tibia was cut longitudinally at the center of the material. Decalcified sagittal sections treated with hematoxylin and eosin staining, undecalcified sagittal sections treated with Villanueva-Goldner staining, and axial unstained sections were used for histological evaluation. The lengths of the largest vessels and newly formed bone at the material border were measured in a sagittal section. Both lengths were significantly larger at 6 weeks than at 2 weeks. In the axial sections at 2 weeks, newly formed vessels filled with blue dye grew along the pores of the UDPTCP. Mature bone tissue with a lamellar structure was observed at 6 weeks. Our histological findings demonstrated that angiogenesis and bone formation occur over time in UDPTCP.

Keywords: Angiogenesis; Beta-tricalcium phosphate artificial bone; New bone formation.

MeSH terms

  • Animals
  • Biocompatible Materials
  • Bone Substitutes
  • Calcium Phosphates*
  • Disease Models, Animal
  • Neovascularization, Physiologic / drug effects*
  • Osteogenesis / drug effects*
  • Porosity
  • Prostheses and Implants*
  • Prosthesis Implantation / methods*
  • Rabbits
  • Tibia / diagnostic imaging
  • Tibia / surgery*

Substances

  • Biocompatible Materials
  • Bone Substitutes
  • Calcium Phosphates
  • beta-tricalcium phosphate

Grants and funding